Eli Lilly is planning a $3.5 billion investment in Pennsylvania, specifically in the Lehigh Valley. The investment is expected to bring over 850 jobs to the area and establish a manufacturing campus, reportedly for the production of weight-loss drugs. The project is being hailed as a significant economic development for the region, potentially putting it in the global spotlight.